Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2023-05-11 00:00:00 ET · period of report 2023-05-10 · accession 0001209191-23-028816 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-10 | CBIO | JUNIUS DANIEL M | Dir | P - Purchase | $1.56 | +30.0K | 93.2K | +47% | +$46.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-10 | P | A | 30,000 | $1.56 | 93,250 | D | — | — |